USS Investment Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
USS Investment Management's CLBT Position: Q2 2026 in Review
USS Investment Management increased its Cellebrite (CLBT) stake by 1,163% in Q2 2026, buying an estimated $8.32M and bringing the position to 683,981 shares worth $9.99M. The position accounts for 0.04% of the portfolio, ranked #299.
USS Investment Management first reported a position in CLBT in Q4 2024 and has held it in 7 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- USS Investment Management held 683,981 shares of Cellebrite worth $9.99M as of Q2 2026.
- USS Investment Management bought 629,840 Cellebrite shares in Q2 2026, an estimated $8.32M.
- Cellebrite made up 0.04% of USS Investment Management's portfolio in Q2 2026, its #299 holding.
- USS Investment Management first reported a position in Cellebrite in Q4 2024 and has held it in 7 quarters since.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.